1043-3155 Pediatr Neurol Briefs pedneurbriefs Pediatr Neurol Briefs Pediatric Neurology Briefs Pediatr Neurol Briefs 2166-6482 1043-3155 2166-3155 Pediatric Neurology Briefs Publishers Chicago, IL, USA PNB-17-16-b 10.15844/pedneurbriefs-17-2-10 Headache Disorders Neurology Pediatrics Nervous System Diseases Child Development Brain Diseases Neurosurgery Child Infant Prognosis of Adolescent Migraine Headache http://orcid.org/0000-0002-0173-7931 Millichap J. Gordon MD 1 2 * Division of Neurology, Children's Memorial Hospital, Chicago, IL Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL Correspondence: Dr. J. Gordon Millichap, E-mail: jgmillichap@northwestern.edu 02 2003 01 03 2016 17 2 16 16 Copyright: © 2003 The Author(s) 2003 This work is licensed under the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Migraine headaches in adolescents: a five-year follow-up study

The prevalence and evolution over 5 years of migraine without aura (MWOA) and migraineous disorder (MD) in 64 adolescent patients (34 girls and 30 boys, mean age 17.3 +/-1.1 years) were studied at the Institute of Neuropsychiatry, University of Palermo, Italy.

 Headache not Classifiable Migraineous Disorder Episodic Tension-Type Headache

The prevalence and evolution over 5 years of migraine without aura (MWOA) and migraineous disorder (MD) in 64 adolescent patients (34 girls and 30 boys, mean age 17.3 +/-1.1 years) were studied at the Institute of Neuropsychiatry, University of Palermo, Italy. Thirty two (50%) had MWOA, 18 (28.1%) had MD, and 14 (21.9%) had headache not classifiable (HnC). MWOA persisted in 56.2%, converted to MD or HnC in 9.4% and 3.1% cases, respectively, changed to episodic tension-type headache (ETTH) in 12.5%, and remitted in 18.8%. MD persisted in 11.1%, converted to MWOA or HnC in 27.8% and 5.5% cases, respectively, changed to ETTH in 11.1%, and remitted in 44.5%. Analgesic drug-use was greater in patients with MWOA than MD (80% cf 37.5%, p= .02). [1]

Camarda R Monastero R Santangelo G Raimondo D Puma D Pipia C Migraine headaches in adolescents: a five-year follow-up study Headache 2002 Nov-Dec 42 10 1000 5 10.1046/j.1526-4610.2002.02229.x 12453031